Kennedy Eugene P. 4
4 · Galera Therapeutics, Inc. · Filed Sep 2, 2022
Insider Transaction Report
Form 4
Kennedy Eugene P.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-09-01+150,000→ 150,000 totalExercise: $1.29Exp: 2032-08-31→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% on September 1, 2023, and in thirty-six (36) substantially equal monthly installments over a three-year period thereafter.